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Synergistic Roles for Pim-1 and c-Myc
in STAT3-Mediated Cell Cycle Progression
and Antiapoptosis
amino acid), which includes Tyr-767, Tyr-814, Tyr-905,
and Tyr-915 of human gp130 (Stahl et al., 1995; Fukada
et al., 1996; Yamanaka et al., 1996). Tyrosine-phosphor-
ylated STAT3 forms a dimer, enters the nucleus, and
regulates a set of genes. SHP-2, the SH2 domain-con-
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to gp130, where its tyrosine phosphorylation is depen-2-2 Yamada-oka, Suita
Osaka 565-0871 dent on binding to phosphorylated Tyr-759 of gp130
(Stahl et al., 1995; Fukada et al., 1996). By using chimericJapan
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plasmic domain of gp130 and by expressing dominant-Imperial Cancer Research Fund
Lincoln's Inn Fields negative forms of STAT3, we have demonstrated roles
for gp130-mediated signals in biological functions in aLondon WC2A 3PX
United Kingdom number of cell lines. STAT3 is required for IL-6-mediated
growth arrest and macrophage differentiation in the
mouse leukemia M1 cells (Nakajima et al., 1996; Yama-
naka et al., 1996). Tyr-759±mediated signals are requiredSummary
for the S to G2/M cell cycle transition in the gp130-
mediated cell proliferation of the mouse proB cell lineThe activation of STAT3 by the cytokine receptor
BAF/B03, and the STAT3 signal is required for bothgp130 is required for both the G1 to S cell cycle transi-
antiapoptosis and for the G1 to S cell cycle transitiontion and antiapoptosis. We found that Pim-1 and Pim-2
(Fukada et al., 1996, 1998). Although c-myc has beenare targets for the gp130-mediated STAT3 signal.
identified as one of the target genes of STAT3 (KiuchiExpression of a kinase-defective Pim-1 mutant attenu-
et al., 1999), it remains largely unknown what moleculesated gp130-mediated cell proliferation. Constitutive ex-
act downstream of Tyr-759±mediated signals and thepression of Pim-1 together with c-myc, another STAT3
STAT3 regulation of cell proliferation.target, fully compensated for loss of the STAT3-medi-
STAT proteins have been shown to play importantated cell cycle progression, antiapoptosis, and bcl-2 ex-
roles in cell proliferation induced by cytokines. STAT5pression. We also identified valosine-containing pro-
was shown to be involved in IL-3-mediated cell prolifera-tein (VCP) as a target gene for the Pim-1-mediated
tion in an IL-3-dependent cell line (Mui et al., 1996).signal. Expression of a mutant VCP led cells to undergo
Targeted disruption of the stat5a and stat5b genes inapoptosis. These results indicate that Pim-family pro-
mice revealed that STAT5 is needed for IL-2-mediatedteins play crucial roles in gp130-mediated cell prolifer-
T cell proliferation and erythropoietin-mediated antiapo-ation and explain the synergy between Pim and c-Myc
ptosis in red cell progenitors (Moriggl et al., 1999; Soco-proteins in cell proliferation and lymphomagenesis.
lovsky et al., 1999). Similarly, targeted disruption of the
stat4 and stat6 genes showed that STAT4 and STAT6Introduction
are required for IL-12- and IL-4-dependent lymphocyte
proliferation, respectively (Kaplan et al., 1996; Takedagp130 is a subunit that is common to the receptors for
et al., 1996; Thierfelder et al., 1996; Akira, 1999). Consti-the interleukin-6 (IL-6) family of cytokines: IL-6, leukemia
tutive activation of STAT is observed in cells trans-inhibitory factor, ciliary neurotrophic factor, IL-11, on-
formed with human T cell leukemia virus 1 (HTLV-1), v-src,costatin M, and cardiotrophin-1, which are involved in
abl, bcr-abl, and v-eyk, and some multiple myelomacell proliferation, differentiation, and cell death in various
cells (Besser et al., 1999; Carlesso et al., 1996; Danialtissues (Hirano et al., 1997). Upon stimulation by these
et al., 1995; Hilbert et al., 1996; Migone et al., 1995;cytokines, gp130 forms a homodimer and activates the
Turkson et al., 1998; Yu et al., 1995). STAT3 activation isgp130-associated Janus tyrosine kinases (JAK1, JAK2,
required for transformation with v-src and for preventingand TYK2) through transphosphorylation, which results
apoptosis in multiple myeloma cells (Bromberg et al.,in the phosphorylation of tyrosine residues on gp130
1998; Catlett-Falcone et al., 1999). Inactivation of theand JAKs (reviewed in Hirano et al., 1997). Tyrosine-
stat3 gene in T cells revealed that STAT3 is requiredphosphorylated gp130 recruits signal-transducing mol-
for IL-6-mediated antiapoptosis, independent of bcl-2ecules that contain Src homology 2 (SH2) domains to
induction (Takeda et al., 1998). A constitutively activeitself, where they are phosphorylated on tyrosine. Signal
mutant of stat3 was recently shown to act as an onco-transducer and activator of transcription 3 (STAT3) is
gene and can act alone to induce tumorigenesis (Brom-an SH2 domain-containing transcription factor. Tyrosine
berg et al., 1999).phosphorylation of STAT3 depends on phosphorylated
Pim-1 is a protooncogene that was first identified astyrosines in the YXXQ motif (where X is an arbitrary
a common insertion site in Molony murine leukemia virus
(MuLV)±induced T cell lymphomas (Cuypers et al., 1984).³ To whom correspondence should be addressed (e-mail: hirano@
The Pim-1 gene encodes two cytoplasmic serine/threo-molonc.med.osaka-u.ac.jp).
nine protein kinases, which are generated by an alterna-§ Present address: Cold Spring Harbor Laboratory, Cold Spring Har-
bor, New York 11724. tive translational initiation (Saris et al., 1991). Em-Pim-1
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Figure 1. Pim-1 and Pim-2 Genes Are Direct
Targets for STAT3
(A) Expression of Pim-1 and Pim-2 upon stim-
ulation of the truncated chimeric receptors.
G277, G133, G68, and G25 cells were stimu-
lated with 100 ng/ml of G-CSF for the indi-
cated periods. Twenty micrograms of total
RNA was analyzed by Northern blotting with
the Pim-1, Pim-2, and CHOB (loading control)
probes.
(B) Expression of Pim-1 and Pim-2 depends
on the gp130-mediated STAT3 signal.
G133F2 cells (in which Tyr-759 was replaced
by phenylalanine), G133F3 cells (Tyr-767 re-
placed by phenylalanine), G133 expressing
the dominant-negative STAT3 D (DN STAT3D),
and G133 expressing the dominant-negative
STAT3F (DN STAT3F), were stimulated with
G-CSF for the indicated periods.
(C) Induction of Pim-1 and Pim-2 genes does
not require de novo protein synthesis. Before
stimulation, G133 cells were treated with 10
mg/ml of cycloheximide (CHX) for 1 hr and stim-
ulated with G-CSF for the indicated periods.
(D) Pim-1 and Pim-2 induction in M1 and KT-3
cells. M1 cells and KT-3 cells (starved of IL-6
for 12 hr) were stimulated with 100 ng/ml of human IL-6 for the indicated periods.
(E) Luciferase assay for the Pim-1 promoter. G133 cells (2 3 106) were transfected with the indicated amounts (mg) of pCAGGS-Neo-HASTAT3D
(DN STAT3D), pCAGGS-Neo (the control vector, pCAGGS), and pGVB-Pim-1, which contains the 1.8 kb Pim-1 promoter region. The cells were
stimulated with G-CSF for 10 hr or left unstimulated. The relative luciferase activities (versus activity in the unstimulated cells) are shown in
a bar graph. The error bars indicate the standard deviation (SD) from triplicate experiments.
transgenic mice are highly susceptible to developing T mouse IL-3-dependent BAF/B03 proB cells (Fukada et
al., 1996). This region of gp130 contains box1 and box2cell lymphoma after MuLV infection and exposure to a
and Tyr-759 and Tyr-767, which are required for the JAKchemical carcinogen, and c-myc or N-myc genes are
activation, SHP2/ERK activation, and STAT3 activation,activated in the resulting lymphomas (Breuer et al., 1989;
respectively. A BAF/B03 transfected cell line expressingvan Lohuizen et al., 1989). Em-myc transgenic mice can
a chimeric receptor composed of the extracellular do-also develop B cell lymphomas when Pim-1 has been
main of the human G-CSF receptor and the transmem-activated by a secondary proviral insertion (van Lohu-
brane and 133 amino acids of the cytoplasmic regionizen et al., 1991). These reports suggest a synergistic
of human gp130 (G133) was used to isolate genes thatrole for Pim-1 and myc genes in lymphomagenesis.
are activated downstream of gp130 signaling. cDNA li-Physiologically, the Pim-1 gene is induced in response
braries were constructed from unstimulated cells andto a number of cytokines such as GM-CSF, G-CSF, IL-3,
cells in which gp130 signaling was activated throughinterferon-a, and IL-6 (Lilly et al., 1992; Sato et al., 1993;
the chimeric receptor by treatment with G-CSF for 2 hrJaster et al., 1999; Matikainen et al., 1999). A homolog
and subjected to a PCR-based subtraction method. Inof Pim-1, Pim-2, has also been implicated in lympho-
this screen, we identified the Pim-1 and Pim-2 protoon-magenesis, and its expression is also regulated by a set
cogenes, which were induced by gp130 stimulation. Toof cytokines that is similar to those that induce Pim-1
determine which signals from gp130 were necessary for(van der Lugt et al., 1995; Allen et al., 1997). It remains
their induction, we performed Northern blot analysis ofunclear how the Pim gene is regulated by other cyto-
different cell lines that expressed mutant forms of gp130
kines, how Pim-1 regulates cell proliferation, and how
(Figure 1). These mutant receptors, which have been
Pim-1 cooperates with Myc proteins to promote cell described previously, were as follows: G277 contains
proliferation and lymphomagenesis. the entire cytoplasmic domain; G68 contains a minimal
Here, we demonstrate that Pim-1 is a target of the region (box1 and box2) for JAK activation but cannot
gp130-mediated STAT3 signal and cooperates with activate the SHP2/ERK and STAT3 pathways; G25 con-
c-myc to promote cell proliferation through the G1 to S tains box1 alone, which is not sufficient to activate the
cell cycle transition and prevent apoptosis. Furthermore, JAKs; and in G133F2 and G133F3, Tyr-759 and Tyr-
we demonstrate that VCP, the mammalian homolog of 767 are replaced by phenylalanines and are unable to
yeast Cdc48p, is a target for Pim-1-mediated signals activate the SHP2/ERK and STAT3 pathways, respec-
and is involved in antiapoptosis. tively (Fukada et al., 1996). Induction of both Pim-1 and
Pim-2 was detected in cells expressing G277, G133,
Results and G133F2, but not G68, G25, or G133F3, indicating
that their expression depended on STAT3 activation
STAT3 Is Required for gp130-Mediated Pim-1 (Figures 1A and 1B). The STAT3-dependent expression
and Pim-2 Expression was further confirmed in cells expressing dominant-neg-
We previously showed that the membrane-proximal ative forms of STAT3 (Figure 1B). IL-6-dependent induc-
133-amino-acid region of the cytoplasmic domain of tion of Pim-1 and Pim-2 was also observed in the Len-
nert's T lymphoma KT-3 cells and M1 cells, suggestinggp130 is sufficient to promote cell proliferation in the
Pim-1 and c-Myc in STAT3-Mediated Cell Growth
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that their induction is not specific to BAF/B03 cells (Fig-
ure 1D). We further performed a reporter assay, in which
the luciferase gene was under control of the 1.8 kb
promoter region of Pim-1. Upon the stimulation of gp130
in the G133 transfectants, a 16-fold induction of the
luciferase activity was observed (Figure 1E). Expression
of the dominant-negative STAT3 (STAT3D) decreased
the induction to about 4-fold, confirming that the Pim-1
induction was dependent on STAT3. This induction
was also observed in cyclohexamide-treated cells, re-
vealing that it did not require protein synthesis (Figure
1C). These results indicate that Pim-1 and Pim-2 are
likely to be direct targets of the gp130-mediated STAT3
signal.
Pim-1 Is Involved in gp130-Mediated
Cell Proliferation
To examine the roles played by Pim proteins in gp130-
mediated cell proliferation, we established a G133 cell
line that stably expresses a mutated form of Pim-1,
K67M Pim-1, in which Lys-67 in the ATP binding domain
was replaced by methionine, rendering its kinase do-
main nonfunctional. We also established a G133 cell
line that expresses the K67M Pim-1 in a doxycycline-
inducible manner. The G133 cells stably expressing the
K67M Pim-1 grew in response to IL-3 but not in response
to gp130 stimulation (data not shown). Concordantly,
the inducible G133 K67M Pim-1 cells grew as well in
response to IL-3 whether or not they were expressing
K67M Pim-1, but the gp130-mediated cell proliferation
that occurred in the absence of K67M Pim-1 expression
was perturbed when K67M Pim-1 expression was in-
duced (Figure 2A). Neither constitutive nor induced ex-
pression of wild-type Pim-1 in the G133 cells changed
the level of cell proliferation by either IL-3 or gp130
Figure 2. Pim-1 and c-Myc Are Required for gp130-Mediated Cellstimulation (data not shown; Figure 2A). These data indi-
Proliferationcate that Pim-1 is required for gp130-mediated cell pro-
(A) Cell proliferation of G133 cells expressing K67M Pim-1. G133-liferation.
wtPim-1 DOX and G133-K67Mpim-1 DOX cells expressed the wild-
type Pim-1 and K67M Pim-1, respectively, in a doxycycline-inducible
Pim-1 Is Not Sufficient to Compensate for Loss manner (Experimental Procedures). The cells were cultured in the
presence of 1 mg/ml of doxycycline for 10 hr before the stimulationof the gp130-Mediated STAT3 Signal
and during the stimulation (1) or in the absence of doxycycline (2).To examine the possibility that Pim-1 could compensate
Cells (5 3 104 cells) were stimulated with G-CSF for the indicatedfor loss of the gp130-mediated STAT3 signal, we estab-
periods, and the numbers of variable cells were counted. Expressionlished a G133F3 cell line that was defective in the STAT3
of endogenous Pim-1 and transfected wild-type (wt) and K67M mu-
signal but constitutively expressed wild-type Pim-1 tant Pim-1 are shown.
(G133F3-Pim-1). Proliferation of the G133F3-Pim-1 cells (B) Cell proliferation of G133F3, G133F3-Pim-1, G133F3-Myc, and
G133F3-Myc/Pim-1. Cells (5 3 104) were cultured in the presencewas not observed in response to gp130 stimulation
of G-CSF for the indicated periods. The numbers of viable cellswithin a few days, and about 80% of the cells underwent
were counted. One representative clone out of at least five indepen-apoptosis. However, about 20% of the cells survived
dent cell lines for each transfection condition is shown.and grew (Figure 2B). We repeated this experiment using
the surviving cells, and after factor starvation, similar
proportions of the cells died and survived in the pres- gp130-mediated STAT3 signal (Kiuchi et al., 1999) and
ence of gp130 stimulation, indicating that the surviving cooperates with Pim-1 to promote lymphomagenesis
cells were not transformed into factor-independent (Breuer et al., 1989; van Lohuizen et al., 1989). To ad-
cells. These data indicate that Pim-1 partially rescued dress this issue, we established G133F3 cell lines that
the defect in the STAT3 signal but that Pim-1 alone was expressed c-Myc alone (G133F3-Myc) or both c-Myc
not sufficient to compensate for the loss of the gp130- and Pim-1 (G133F3-Myc/Pim-1). The G133F3-Myc cells
mediated STAT3 signal. did not grow in response to gp130 stimulation and un-
derwent apoptosis in response to the withdrawal of IL-3
faster than did the G133F3 cells (Figures 2B, 3A, andPim-1 Cooperates with c-Myc to Promote Cell Cycle
Progression and Prevent Apoptosis 3B), consistent with there being a role for c-Myc in apo-
ptosis, as reported (Askew et al., 1991; Evan et al., 1992).Pim-1 seemed likely to cooperate with other targets that
act downstream of the STAT3 signal. c-myc was a strong In contrast, the G133F3-Myc/Pim-1 cells grew as well
as the G133 cells in a manner dependent on gp130candidate for such a role, since it is regulated by the
Immunity
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Figure 3. Pim-1 Cooperates with c-Myc in
gp130-Mediated Antiapoptosis
(A) Overexpression of c-Myc enhances apo-
ptosis induced by cytokine starvation. 5 3
104 G133F3-Myc (two each of clones 1 and
2) and G133F3 cells were starved of IL-3 and
G-CSF for 12 hr. The numbers of viable and
dead cells were counted, and the percent-
ages are shown.
(B) DNA fragmentation. 1 3 106 G133F3,
G133F3-Myc, G133F3-Myc/Pim-1, and G133-
Myc/Pim-1 cells were starved of IL-3 for 12
hr (S) and cultured in the presence of G-CSF
(1) or IL-3 (IL-3) or in the absence of the fac-
tors (2) for additional 10 hr. The cells were
lysed, and the chromosomal DNA was frac-
tionated on 2% agarose gels.
(C) Expression of bcl-2. G133-K67Mpim-1
DOX cells were stimulated with G-CSF in the
presence (1) or absence (2) of the doxycycline
treatment (upper panel). G133, G133F3-Pim-1,
G133F3-Myc/Pim-1, and G133F3 cells were
stimulated with G-CSF after starving them of
IL-3 (lower panel). Expression of bcl-2, c-myc,
and CHOB was analyzed by Northern
blotting.
stimulation (Figure 2B). These data indicate that coex- To examine whether Pim-1 is required solely to pre-
vent apoptosis or whether it is also needed for cell cyclepression of Pim-1 with c-myc prevents apoptosis and/
or promotes cell cycle progression. We previously ob- progression, we established a line of G133F3-Myc cells
expressing bcl-2 (G133F3-Myc/Bcl-2) and comparedserved that expression of the antiapoptotic gene bcl-2
is regulated by the gp130-mediated STAT3 signal (Fu- them with the G133F3-Myc/Pim-1 cells. It was reported
previously that the constitutive expression of c-myc andkada et al., 1996). The induction of bcl-2 in response
to gp130 stimulation was diminished in the G133 cells bcl-2 enables BAF-B03 cells to grow independent of
factor availability (Miyazaki et al., 1995). However, in ourexpressing K67M Pim-1 (Figure 3C). Although the induc-
tion of bcl-2 was not observed in the G133F3 cells, it was hands, five cell lines derived from separate clones of
G133F3-Myc/Bcl-2 cells, which expressed c-myc anddetected in the G133F3-Pim-1 cells, and its enhanced
induction was observed in the G133F3-Myc/Pim-1 cells bcl-2 at levels comparable to those seen in stimulated
G133 cells, survived but did not grow in response to(Figure 3C). These results suggest that Pim-1 is primarily
involved in the bcl-2 induction and c-Myc cooperates gp130 stimulation (Figures 3B and 4). Our data indicate
that neither the expression of c-myc alone nor of c-mycwith Pim-1 to induce bcl-2 expression. Consistent with
this, IL-3 deprivation±induced apoptosis in G133F3- and bcl-2 led to the complete activation of cell cycle
progression. In contrast, coexpression of Pim-1 withMyc/Pim-1 was prevented by gp130 stimulation (Figure
3B). The bcl-2 induction was observed only in the stimu- c-myc was sufficient to promote the cell cycle in a man-
ner dependent on gp130 stimulation without STAT3 acti-lated G133F3-Myc/Pim-1 cells, suggesting that other
signals from gp130 are also involved in bcl-2 expression. vation, indicating that Pim-1 is also required for cell
Pim-1 and c-Myc in STAT3-Mediated Cell Growth
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VCP (G133F3-VCP) or both VCP and c-Myc (G133F3-
Myc/VCP) (Figure 6A). Most of the G133F3-VCP cells
underwent apoptosis, even upon the stimulation of
gp130 with G-CSF, but a small population (,10%) of
cells survived and grew in a manner dependent on gp130
stimulation. This situation was similar to that in the
G133F3-Pim1 cells, but a smaller proportion of the
G133F3-VCP cells survived. Coexpression of c-Myc with
VCP increased the proportion of the cells that initially
survived, but it enhanced apoptosis after the third day
(Figure 6A). These results suggest that VCP is able to
compensate for part of the Pim-1 function.
To examine whether VCP is required for gp130-medi-
ated cell proliferation, we constructed a VCP mutantFigure 4. Pim-1 Cooperates with c-Myc in gp130-Mediated Cell Cy-
and established a G133 cell line expressing the wild-cle Progression
type or the mutant VCP molecules in a doxycycline-G133F3-Myc/Bcl-2 and G133F3-Myc/Pim-1 cells were stimulated
with G-CSF, fixed at the indicated time, and stained with propidium inducible manner. VCP is an ATPase protein that be-
iodide. Their status in the cell cycle was analyzed by FACS. 1N and longs to the superfamily of AAA (ATPases associated
2N indicate the G0/G1 phase and G2/M phase of the cell cycle, with a variety of cellular activities) (Frohlich et al., 1995).
respectively. VCP contains two ATPase domains, which consist of a
Walker A cassette for ATP binding and a Walker B cas-
sette for ATP hydrolysis (Egerton et al., 1992). The K251/
cycle progression (Figure 4B). These results indicate 524A-VCP mutant was constructed by replacing Lys-
that both Pim-1 and c-Myc are required and sufficient 251 and Lys-524 in the Walker A cassettes by alanines
for effecting the STAT3-mediated antiapoptosis function (Figure 6B). Expression of the K251/524A-VCP mutant
and cell cycle progression. in G133 cells strongly inhibited gp130-dependent cell
proliferation, indicating that the K251/524A-VCP mutant
VCP (Cdc48p) Is a Target for the Pim-1 Signal acts as a dominant-negative molecule for VCP function
To understand the mechanism(s) by which Pim-1 regu- (Figure 6C). The cells expressing the K251/524A-VCP
lates antiapoptosis and cell cycle progression, we per- mutant underwent apoptosis, as assessed by observ-
formed a cDNA subtraction using the G133F3-Pim-1 and ing DNA fragmentation (Figure 6D). Furthermore, bcl-2
G133F3 cells stimulated with G-CSF to isolate genes induction was suppressed in the K251/524A-VCP-
expressed only in the G133F3-Pim-1 cells but not in the expressing cells (Figure 6E). These data indicate that
G133F3 cells. We identified VCP, the mammalian homolog VCP, a target for Pim-1, is required for both the preven-
of yeast Cdc48p, in this screen. Expression of VCP was tion of apoptosis and the expression of bcl-2 in gp130-
detected after 3 hr of stimulation (Figure 5A) in G133 mediated cell proliferation.
cells, which was slightly later than the expression of
Pim-1. Its expression was observed in G133F2 cells, but Discussion
the level of expression was quite reduced in G133F3
cells. Greatly reduced levels of expression were also Pim-1, Pim-2, and c-myc Are Targets for the
seen in G133 cells expressing the dominant-negative gp130-Mediated STAT3 Signal
STAT3s (DNSTAT3F and DNSTAT3D) and in G133 cells We demonstrated that Pim-1 and Pim-2 are direct tar-
expressing K67M Pim-1 (Figure 5A). Expression of VCP gets for the gp130-mediated STAT3 signal (Figure 1).
was also observed in IL-6-stimulated KT-3 and HepG2 Pim-1, Pim-2, and c-myc are immediate early genes
cells, IL-3-stimulated BAF/B03 cells, and IL-2-stimu- that are all induced by the same cytokines. In the IL-3
lated KT-3 cells, suggesting that the induction of VCP signaling pathway, the membrane-proximal region of the
is not specific to BAF/B03 cells or to gp130 signaling common b-chain for the IL-3/IL-5/GM-CSF receptors,
(Figure 5A). We further performed a reporter gene assay, which contains box1 and box2, is responsible for the
in which the luciferase gene was driven by the 400 bp signals that induce the expression of both Pim-1 and
promoter region in the 59 flanking region of the mouse c-myc (Sato et al., 1993; Mui et al., 1996). However,
VCP gene. 5-fold induction of luciferase activity was expression of Pim-1 depends on STAT5 but expression
observed upon gp130 stimulation in the G133 cells, and of c-myc does not (Mui et al., 1996). In contrast, the
2.5- to 3-fold induction was observed upon transfection gp130-dependent expression of the Pim genes and
with the Pim-1 expression vector (Figures 5B and 5C). c-myc mainly depended on the STAT3 signal (Figure 1),
These data indicate that VCP is a target gene for the indicating that the Pim genes and c-myc are differently
Pim-1-dependent signal. Expression of VCP in the regulated in the signaling of the IL-3 receptor and gp130.
G133F3-Pim-1 cells was further enhanced by gp130 This is consistent with the observation that dominant-
stimulation, suggesting that VCP may also be regulated negative STAT3s inhibit the gp130-mediated but not
by other signals (Figure 5A). IL-3-dependent cell proliferation (Fukada et al., 1996),
which probably involves the functions of the Pims and
c-Myc. The 1.8 kb 59-flanking region of the Pim-1 geneVCP Is Involved in gp130-Mediated Cell Proliferation
To reveal the role(s) of VCP in gp130-mediated cell prolif- was sufficient to induce Pim-1 in response to gp130
stimulation (Figure 1E). This region does not containeration, we established a G133F3 cell line expressing
Immunity
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Figure 5. VCP Is a Direct Target for the Pim-
1-Mediated Signal
(A) Expression of VCP. The transfected cell
lines were stimulated with 100 ng/ml G-CSF.
G133 cells were also stimulated with 50 ng/
ml mouse IL-3. HepG2 cells were stimulated
with 100 ng/ml human IL-6. KT-3 cells were
stimulated with 50 ng/ml human IL-2 or 100
ng/ml human IL-6. Expression of VCP and
CHOB are shown.
(B) Expression of VCP in response to the
gp130 stimulation. G133 cells were trans-
fected with 4 mg pGL2-p97(1), the VCP pro-
moter-containing reporter gene, and stimu-
lated with G-CSF for 10 hr (1) or left
unstimulated (2). The relative luciferase ac-
tivity (versus activity in the unstimulated cells)
is shown. The error bars indicate SD.
(C) Pim-1-dependent activation of the VCP
promoter. G133 cells were transfected with
the indicated amounts of pCAGGS-Neo-
Pim-1 (wtPim-1), pCAGGS-Neo (pCAGGS),
and pGL2-p97(1). The cells were harvested
10 hr after transfection, and their luciferase
activities were determined.
the consensus sequence for STAT binding. However, 2A), implicating Pim-1 in that function as well. The in-
complete inhibition may be caused by insufficient ex-cooperative binding of STAT to DNA modifies the speci-
pression of the mutant Pim-1, or Pim-2 may rescue itsficity of STAT binding (Xu et al., 1996). Consistent with
effect. Mice deficient for the Pim-1 gene display a subtlethis, the Pim-1 promoter contains a DNA sequence that
phenotype, with a decreased response to IL-3 and IL-7potentially binds STAT oligomers (data not shown). Al-
in bone marrow±derived mast cells and early B cellternatively, STAT3 may cooperate with other transcrip-
progenitors, respectively (Domen et al., 1993a, 1993b,tion factors to bind the promoter region to regulate Pim-1
1993c). Pim-2 and/or the recently identified Pim-3 (Ko-expression.
nietzko et al., 1999) may largely compensate for the
Pim-1 deficiency in these mice.
Synergistic Roles of Pim-1 and c-Myc The constitutive expression of Pim-1 and c-myc did
in Cell Proliferation not lead to factor-independent proliferation in BAF/B03
A line of evidence shows that activation of the Pim-1 cells, indicating that other signals from gp130 than the
and c-myc genes cooperatively promotes oncogenesis STAT3 signal are likely to be involved in the cell prolifera-
in T and B lymphocytes (Breuer et al., 1989; van Lohuizen tion. These results contradict a previous report show-
et al., 1989), implying that Pim-1 and c-Myc also play ing that overexpression of Pim-1 induced IL-3-indepen-
physiological roles in the cell proliferation induced by dent cell proliferation in BAF-B03 cells (Nosaka et al.,
cytokines. In this report, we found that enforced expres- 1999). We established more than five independent lines
sion of either Pim-1 or c-myc alone was not sufficient of G133F3-Pim-1 and G133F3-Myc/Pim-1, which ex-
to complement the gp130-mediated STAT3 signal for pressed Pim-1 and c-myc at levels similar to those in
cell proliferation (Figure 2B). However, expression of stimulated G133 cells, and none of the lines displayed
both genes completely rescued the defect in the STAT3 factor-independent cell proliferation (Figure 2B). Our
signal, revealing that Pim-1 and c-myc are major targets data imply that Pim-1 and c-myc induced by the gp130-
for the STAT3 signal that transduce the gp130-mediated mediated STAT3 signal are not sufficient to elicit factor-
cell proliferation. Furthermore, expression of a Pim-1 independent cell proliferation. Studies of lymphomagen-
mutant that lacked a functional kinase domain partially esis and leukemiagenesis suggest that, in cooperation
with Pim-1 and c-myc, the activation of other genesattenuated the gp130-mediated cell proliferation (Figure
Pim-1 and c-Myc in STAT3-Mediated Cell Growth
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Figure 6. VCP Is Involved in gp130-Mediated
Cell Proliferation and Antiapoptosis
(A) Cell proliferation of G133F3, G133F3-VCP,
and G133F3-Myc/VCP. The transfectant cells
were cultured in the presence of G-CSF, and
the numbers of viable cells were counted.
Data from two representative clones for
G133F3-VCP and G133F3-VCP/Myc are
shown.
(B) Wild-type VCP (wtVCP) and K251/254A-
VCP mutant. Lys-251 and Lys-524 in the
Walker A cassettes of the ATP binding do-
mains were replaced by alanines. WA; Walker
A cassette, WB; Walker B cassette.
(C) Cell proliferation in G133 cells expressing
the K251/254A-VCP mutant. G133 cells that
expressed K251/524A-VCP in a doxycycline-
inducible manner (G133-K251/524-VCP cells)
were cultured in the presence of G-CSF with
(1) or without (2) doxycycline. The numbers
of the viable cells were counted on the day
indicated.
(D) Apoptosis mediated by K251/524A-VCP.
2 3 105 G133-K251/524A-VCP DOX cells were
stimulated with G-CSF for 20 hr (1) or left
unstimulated (2) in the presence (1) or ab-
sence (2) of doxycycline. The DNA fragmen-
tation assay was performed.
(E) Bcl-2 expression in G133-K251/524-VCP
cells. Cells were stimulated with 100 ng/ml
G-CSF for the indicated periods in the pres-
ence(1) or absence(2) of doxycycline. Ex-
pression of bcl-2 and CHOB was analyzed by
Northern blotting analysis.
such as bmi-1 and gfi-1 promotes oncogenesis (van might be restricted to preventing c-Myc-mediated apo-
ptosis. However, this was not the case. CoexpressionLohuizen et al., 1991; Schmidt et al., 1998). These genes
may act downstream of gp130 and support STAT3- of bcl-2 prevented c-Myc-mediated apoptosis but did
not rescue the G1 to S cell cycle transition (Figures 3Bmediated cell proliferation.
Pim-1 was also induced upon the gp130 stimulation and 4). In contrast, coexpression of c-Myc and Pim-1
promoted the G1 to S cell cycle transition, indicatingin M1 cells (Figure 1D), which stop cell proliferation and
differentiate to macrophages. The roles of Pim-1 in M1 that Pim-1 is not only involved in preventing apoptosis
but is also involved in the G1 to S transition (Figure 4).cells may be different from those in BAF-B03 cells, as
the STAT3-mediated signals exert the opposite actions cdc25A is a direct target gene of c-Myc. Its product
regulates the activity of cyclin-dependent kinasesbetween these cell lines, and gp130 stimulation down-
regulates c-myc expression in M1 cells (Nakajima et al., (CDKs) through the dephosphorylation of threonine and
tyrosine residues (Galaktionov et al., 1996). It was re-1996; Yamanaka et al., 1996). It would be important
to reveal the differences in function of Pim proteins in cently reported that Pim-1 phosphorylates Cdc25A and
activates its phosphatase activity (Mochizuki et al.,different cell types.
1999). Thus, Pim-1 may control the G1 to S transition
by activating Cdc25A.Roles for Pim-1 and c-Myc in Cell Cycle Progression
We previously demonstrated that STAT3 is required for
the gp130-mediated G1 to S cell cycle transition (Fukada
et al., 1998). c-Myc is known to be a major regulator for Roles for Pim-1 and c-Myc in Inhibiting Apoptosis
Forced expression of Pim-1 was shown to enhance fac-the G1 to S transition and is induced by the gp130-
mediated STAT3 signal (Kiuchi et al., 1999), suggesting tor-independent survival and inhibit apoptosis in certain
cell lines (Lilly and Kraft, 1997). The induction of Pim-1that the expression of c-Myc alone might be sufficient
to promote the G1 to S transition and that Pim-1's role correlates with bcl-2 induction in a number of cell lines
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VCP expression was induced not only by gp130 stimula-
tion but also by IL-2 and IL-3, suggesting that regulation
of VCP expression is inductive rather than constitutive
in certain cells. This is consistent with a previous report
showing that the promoter region of VCP contains DNA
elements responsive to a variety of stimuli (Muller et al.,
1999).
VCP and Cdc48p exhibit a variety of biological func-
tions. In budding yeast, Cdc48p plays a role in the segre-
gation of cells during the mitosis phase (Frohlich et al.,
1991). Yeast cells with a specific mutant allele of Cdc48p
display an apoptotic phenotype (Madeo et al., 1997).
Similarly, it was reported that MAC-1, a Caenorhabditis
elegans homolog of VCP/Cdc48p, interacts with CED3,
CED4, and CED9 and inhibits apoptosis in the nematode
(Wu et al., 1999). VCP may prevent apoptosis through
modifying the functions of caspases, Apaf-1, and
Bcl-2, which are the mammalian homologs of CED3,
CED4, and CED9, instead of through regulating bcl-2
expression.
In summary (Figure 7), Pim-1 and c-Myc, downstream
of the gp130-mediated STAT3 signal, cooperatively reg-
ulate cell cycle progression and the prevention of apo-
ptosis. VCP is a key regulator that links the Pim-1 signal
to various biological functions.
Experimental Procedures
Isolation of Pim-1, Pim-2, and VCP Genes
Figure 7. Model for Synergistic Roles Played by Pim-1 and c-Myc The cDNA subtraction was carried out by a PCR-based method
Downstream of the gp130-Mediated STAT3 Signal using the PCR-Select cDNA subtraction Kit (Clontech) according to
For details, see the Discussion. the manufacturer's protocol. To isolate genes induced upon gp130
stimulation, poly A1 RNA was prepared from 1 3 108 G133 cells
stimulated with 100 ng/ml G-CSF for 2 hr and from unstimulated
G133 cells. The positive clones were sequenced by an ALF Redand by various stimuli (Sakai and Kraft, 1997; Krumen-
automated DNA sequencer (Amersham Pharmacia Biotech), andacker et al., 1998). Overexpression of Bcl-2 prevents
two positive clones were found to be the mouse Pim-1 and Pim-2
c-myc-induced apoptosis (Bissonnette et al., 1992; genes.
Wagner et al., 1993). These data imply a connection Similarly, to isolate genes downstream of the Pim-1 signal, poly
between Pim-1 and bcl-2. In this report, we demon- A1 RNA was isolated from 1 3 108 G133F3-Pim-1 and G133F3 cells
stimulated with 100 ng/ml G-CSF for 3 hr. Only one positive clonestrated that Pim-1 was required for bcl-2 induction, and
was also found to be positive, and it was identified as the mouseforced expression of Pim-1 partly compensated for loss
VCP gene.of the STAT3-mediated bcl-2 expression (Figure 3C).
Furthermore, coexpression of Pim-1 and c-Myc en-
Plasmid Construction
hanced bcl-2 induction and prevented apoptosis in cells Expression vectors for Pim-1 were constructed from pSP72-Pim-1
with a defective STAT3 signal (Figure 3C). These data (a gift from Dr. A. Berns) (Selten et al., 1986). To construct the K67M
Pim-1cDNA, Lys-67 in the ATP binding domain was replaced by asuggest that Pim-1 plays a primary role in bcl-2 induc-
methionine using PCR-mediated mutagenesis. Myc-tagged Pim-1tion, and c-Myc cooperates with Pim-1 for bcl-2 induc-
and K67M Pim-1 cDNA were inserted to pcDNA3 (Invitrogen),tion and antiapoptosis. Furthermore, the expression of
pCAGGS-Neo, and pUHD10-3 (Kistner et al., 1996).a mutant VCP inhibited bcl-2 expression (Figure 6E) and
To construct a reporter gene for the promoter of Pim-1, the 1.8
resulted in apoptosis (Figure 6D), indicating that VCP kb SacI±SacII fragment (from 21705 to 155, 1 defined as the tran-
mediates the Pim-1-mediated antiapoptotic signals. scriptional initiation site) was excised from the mouse Pim-1 geno-
mic DNA (a gift from Dr. A. Berns) (Selten et al., 1986) and was
inserted into pGVB (Toyo inki, pGVB-Pim-1).Role of VCP in Cell Proliferation
To construct an expression vector for murine VCP, the VCP cDNAWe identified VCP as a target gene for Pim-1. Forced
fragment, which was fused to a Myc epitope at the carboxyl termi-expression of VCP, or VCP and c-Myc, partially rescued
nus, was excised from pSXSRa-VCP-myc (a gift from Dr. L. E. Samel-
cells with a defect in STAT3 activation (Figure 6A). In- son; Egerton et al., 1992) and subcloned into pTrace-EF (Invitrogen,
duced expression of a mutant form of VCP inhibited pTrace-EF-VCP). The VCP cDNA fragment was inserted into
pUHD10-3 (pUHD10-3 VCP). To construct the K251/524A-VCP mu-gp130-mediated antiapoptotic signals (Figures 6D and
tant, Lys-251 and Lys-524 in the Walker A cassettes in the ATP6E). These data indicate that VCP participates in the
binding domain were replaced by alanines using PCR-mediatedgp130-mediated antiapoptosis function and likely in cell
mutagenesis (pUHD10-3 K251/524A-VCP). Details of the construc-cycle progression as well. However, constitutive expres-
tion are available upon request.
sion of VCP did not compensate fully for loss of the pcDNA3-c-Myc and pUC-CAGGS-bcl2 were previously described
Pim-1 signal, suggesting that genes other than VCP are and were gifts from Drs. Y. Kuchino (Kagaya et al., 1997) and Y.
Tujimoto (Shimizu et al., 1996), respectively. pCAGGS-Neo,required for transmitting the Pim-1 signal. Intriguingly,
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